Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma

Дата публикации: 30-07-2026 00:00:00

This randomized clinical trial evaluates whether combining transarterial chemoembolization with subsequent thermal ablation improves clinical outcomes compared with transarterial chemoembolization alone in patients with liver-confined unresectable hepatocellular carcinoma.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer	0	5	18-06-2026
2	Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer	0	14.28	01-01-2025
3	Individualized Stereotactic Ablative Radiotherapy for Lung Tumors	0	6.6	01-11-2023
4	Thermal Ablation for Papillary Thyroid Microcarcinoma	0	6.4	01-04-2026
5	Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk Breast Cancer	0	18.85	30-07-2026
6	Intermediate histotripsy dose boosts tumor regression in liver cancer model	0	9.64	13-08-2026
7	MASH Comorbidity Burden and Overall, Waiting List, and Post–Liver Transplant Mortality	0	8.64	05-08-2026
8	New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer	5	7	02-07-2026
9	Liver cancer experts co-author new treatment framework for hepatocellular carcinoma	0	9.92	10-08-2026
10	Mesenchymal Stem Cells for Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant	0	7.27	01-02-2024

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5.96. Источник: archderm.jamanetwork.com.